Overview
AAPS PharmSciTech is an official journal of the American Association of Pharmaceutical Scientists, focusing on the research, development, and evaluation of pharmaceutical dosage forms and delivery systems.
- Innovative in its content and practices, AAPS PharmSciTech uses technologically-driven tools and methods by which the scientific community can more efficiently disseminate their research.
- Administers fast peer review with an average first decision time of 30 days.
- Distinguished teams of international Editors and Editorial Advisory Board.
- International readership with nearly 500,000 downloads per year.
- Uses the continuous publishing model, allowing immediate citation upon publication.
- Offers free color publication and supplemental files, including video.
- Main Editor
-
- Robert O. Williams
- Journal Impact Factor
- 3.4 (2023)
- 5-year Journal Impact Factor
- 3.5 (2023)
- Downloads
- 914,757 (2023)
Societies and partnerships
Latest articles
Journal updates
-
The AAPS Journals Make Use of Portable Peer Review
If your manuscript has been declined, and you are planning to submit your article to another of the four AAPS journals (AAPS Open, The AAPS Journal, AAPSPharmSciTech, or Pharmaceutical Research), we can help make the peer review process faster and smoother by extending the use of previous peer reviewer comments! Portable Peer Review, an opt-into service available for any author of these journals, allows us to share, between the portfolio, previous peer review comments and reviewer names, subject to approval of all parties. This can help speed up the assessment process, should the editor choose to make a decision on the basis of the comments and revision. Interested? Email us with the name of the journal to which you are going to submit. Note: Portable peer review is opt-in only, available at the authors’ preference, and the reviewer identities and comments will only be shared between offices, not to the author.
-
AAPS PharmSciTech High Impact Article Award
AAPS PharmSciTech High Impact Article Award Recognizing an article published in the last two years in AAPS PharmSciTech that is judged exceptional by the editors for its impact on pharmaceutical technology.
Awardee/Corresponding Author: Peter Mack, Ph.D., Astrazeneca Co-Authors: Amber Doty, Jon Schroeder, Kou Vang, Mark Sommerville, Ph.D., Mervin Taylor, Brad Flynn, and David Lechuga-Ballesteros, Ph.D.
-
Announcing new Editor-in-Chief of AAPS Open: Dr. Andrea Allmendinger
AAPS Open is proud to announce new Editor-in-Chief Dr. Andrea Allmendinger. Dr. Allmendinger obtained her PhD in Pharmaceutical Technology from the University of Basel and joined the Pharmaceutical Development department of Roche/Genentech in Basel in 2013, where she is responsible for formulation and process development for clinical Phase I-III projects and commercial transfer activities for both large molecules and for synthetic drugs.
Journal information
- Electronic ISSN
- 1530-9932
- Co-Publisher information
- American Association of Pharmaceutical Scientists
- Abstracted and indexed in
-
- ANVUR
- BFI List
- Baidu
- CLOCKSS
- CNKI
- CNPIEC
- Chemical Abstracts Service (CAS)
- Dimensions
- EBSCO
- EMBASE
- Google Scholar
- INIS Atomindex
- Japanese Science and Technology Agency (JST)
- Medline
- Meta
- Naver
- Norwegian Register for Scientific Journals and Series
- OCLC WorldCat Discovery Service
- Portico
- ProQuest
- Reaxys
- SCImago
- SCOPUS
- Science Citation Index Expanded (SCIE)
- TD Net Discovery Service
- UGC-CARE List (India)
- Wanfang
- Copyright information